File: /home/govancoz/mail/.spam/new/1714925478.M255977P1215871.zacp120.ve.host,S=9061,W=9223
Return-Path: <oqituvchi1116@jizpi.uz>
Delivered-To: govancoz+spam@zacp120.ve.host
Received: from zacp120.ve.host
by zacp120.ve.host with LMTP
id Km1CDqavN2Z/jRIAvcbEzQ
(envelope-from <oqituvchi1116@jizpi.uz>)
for <govancoz+spam@zacp120.ve.host>; Sun, 05 May 2024 18:11:18 +0200
Return-path: <oqituvchi1116@jizpi.uz>
Envelope-to: candice@govan.co.za
Delivery-date: Sun, 05 May 2024 18:11:18 +0200
Received: from [185.196.214.17] (port=49402 helo=localhost.localdomain)
by zacp120.ve.host with esmtps (TLS1.2) tls TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384
(Exim 4.97.1)
(envelope-from <oqituvchi1116@jizpi.uz>)
id 1s3eSJ-000000056CR-07jX
for candice@govan.co.za;
Sun, 05 May 2024 18:11:18 +0200
DKIM-Signature: v=1; a=rsa-sha256; q=dns/txt; c=relaxed/relaxed; d=jizpi.uz;
s=mail; h=Message-Id:Reply-To:Date:From:To:Subject:MIME-Version:Content-Type
:Sender:Cc:Content-Transfer-Encoding:Content-ID:Content-Description:
Resent-Date:Resent-From:Resent-Sender:Resent-To:Resent-Cc:Resent-Message-ID:
In-Reply-To:References:List-Id:List-Help:List-Unsubscribe:List-Subscribe:
List-Post:List-Owner:List-Archive;
bh=8No6DlpxOpQe6z+4mvM+6OvnfPMbTDuEkUta+pT4Ufw=; b=icSOShSfMjazs2qj++tz0OwKpx
nogqdmIsMtyMKTzoGbCH+Q8bGZCIvaPz8AarR/GWEMFJayG9OAWNe0rxvfxFkCmh9Ij49USDhrCM+
nCPEq3WO++Y3CP87FKEKbkvyTffSQQ08H548A67Dg9Ls69NBFfvqX4hwYQri2sHLrSx4=;
Received: from [52.165.80.192] (helo=HIghendKapil-pr.kxxfkeiu0z1uti4ymcljbydfhf.gx.internal.cloudapp.net)
by localhost.localdomain with esmtpa (Exim 4.92.3)
(envelope-from <oqituvchi1116@jizpi.uz>)
id 1qspun-0003bi-9q; Wed, 18 Oct 2023 00:39:41 +0500
Content-Type: multipart/alternative; boundary="===============1864159637=="
MIME-Version: 1.0
To: Recipients <oqituvchi1116@jizpi.uz>
From: "Dr. Yasunobu Otsuga" <oqituvchi1116@jizpi.uz>
Date: Tue, 17 Oct 2023 19:39:13 +0000
Reply-To: yasunobuotsuga1@gmail.com
Message-Id: <E1qspun-0003bi-9q@localhost.localdomain>
X-Spam-Status: Yes, score=7.4
X-Spam-Score: 74
X-Spam-Bar: +++++++
X-Spam-Report: Spam detection software, running on the system "zacp120.ve.host",
has identified this incoming email as possible spam. The original
message has been attached to this so you can view it or label
similar future email. If you have any questions, see
root\@localhost for details.
Content preview: Hello Daito Pharma Co., Ltd. is a Japan-based manufacturing
pharmaceutical company engaged in the pharmaceutical ingredients and formulation
business . Are you interested in working with us to be our [...]
Content analysis details: (7.4 points, 5.0 required)
pts rule name description
---- ---------------------- --------------------------------------------------
0.2 FREEMAIL_REPLYTO_END_DIGIT Reply-To freemail username ends in
digit
[yasunobuotsuga1[at]gmail.com]
0.5 SUBJ_ALL_CAPS Subject is all capitals
-0.0 SPF_PASS SPF: sender matches SPF record
0.0 HTML_MESSAGE BODY: HTML included in message
0.1 DKIM_SIGNED Message has a DKIM or DK signature, not necessarily
valid
2.0 PYZOR_CHECK Listed in Pyzor
(https://pyzor.readthedocs.io/en/latest/)
0.0 KAM_DMARC_STATUS Test Rule for DKIM or SPF Failure with Strict
Alignment
2.0 RDNS_NONE Delivered to internal network by a host with no rDNS
0.1 DKIM_INVALID DKIM or DK signature exists, but is not valid
2.5 FREEMAIL_FORGED_REPLYTO Freemail in Reply-To, but not From
X-Spam-Flag: YES
Subject: ***SPAM*** ABOUT PARTNERSHIP WITH DAITO PHRMA.
You will not see this in a MIME-aware mail reader.
--===============1864159637==
Content-Type: text/plain; charset="utf-8"
MIME-Version: 1.0
Content-Transfer-Encoding: quoted-printable
Content-Description: Mail message body
Hello =
Daito Pharma Co., Ltd. is a Japan-based manufacturing pharmaceutical comp=
any engaged in the pharmaceutical ingredients and formulation business . Ar=
e you interested in working with us to be our company representative in you=
r country, The Republic of South Africa, for a period of five years contrac=
t? Please Kindly let us know if you are interested while I direct you to m=
y working company email address =
Apologies for using my personal email address for these proposals. However=
, The reason was to get an immediate notification from you once you respond=
ed. =
Best regards,
Dr. Yasunobu Otsuga President & CEO Daito Pharmaceutical Co., Ltd. 326 Yoka=
machi, Toyama City, Toyama Prefecture 939-8567
--===============1864159637==
Content-Type: text/html; charset="utf-8"
MIME-Version: 1.0
Content-Transfer-Encoding: quoted-printable
Content-Description: Mail message body
<HTML><head><meta http-equiv=3D"Content-Type" content=3D"text/html; charset=
=3Dutf-8"/></head><BODY><DIV style=3D"FONT-SIZE: small; FONT-FAMILY: Arial,=
Helvetica, sans-serif; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSF=
ORM: none; FONT-WEIGHT: 400; COLOR: rgb(34,34,34); FONT-STYLE: normal; ORPH=
ANS: 2; WIDOWS: 2; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-l=
igatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px=
; text-decoration-thickness: initial; text-decoration-style: initial; text-=
decoration-color: initial">Hello</DIV>
<DIV style=3D"FONT-SIZE: small; FONT-FAMILY: Arial, Helvetica, sans-serif; =
WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: =
400; COLOR: rgb(34,34,34); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; LETTE=
R-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-v=
ariant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-thickn=
ess: initial; text-decoration-style: initial; text-decoration-color: initia=
l"><BR></DIV>
<DIV style=3D"FONT-SIZE: small; FONT-FAMILY: Arial, Helvetica, sans-serif; =
WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: =
400; COLOR: rgb(34,34,34); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; LETTE=
R-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-v=
ariant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-thickn=
ess: initial; text-decoration-style: initial; text-decoration-color: initia=
l">Daito Pharma Co., Ltd. is a Japan-based manufacturing pharmaceutic=
al company engaged in the pharmaceutical ingredients and formulation busine=
ss . Are you interested in working with us to be our company representative=
in your country, The Republic of South Africa, for a period of five years =
contract? Please Kindly let us know if you are interested while I dir=
ect you to my working company email address</DIV>
<DIV style=3D"FONT-SIZE: small; FONT-FAMILY: Arial, Helvetica, sans-serif; =
WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: =
400; COLOR: rgb(34,34,34); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; LETTE=
R-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-v=
ariant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-thickn=
ess: initial; text-decoration-style: initial; text-decoration-color: initia=
l">
<DIV><BR></DIV>
<DIV>Apologies for using my personal email address for these proposals. How=
ever, The reason was to get an immediate notification from you once you res=
ponded.</DIV></DIV>
<DIV style=3D"FONT-SIZE: small; FONT-FAMILY: Arial, Helvetica, sans-serif; =
WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: =
400; COLOR: rgb(34,34,34); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; LETTE=
R-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-v=
ariant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-thickn=
ess: initial; text-decoration-style: initial; text-decoration-color: initia=
l"><BR></DIV>
<DIV style=3D"FONT-SIZE: small; FONT-FAMILY: Arial, Helvetica, sans-serif; =
WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: =
400; COLOR: rgb(34,34,34); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; LETTE=
R-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-v=
ariant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-thickn=
ess: initial; text-decoration-style: initial; text-decoration-color: initia=
l">
<DIV><SPAN style=3D"FONT-SIZE: 11pt; FONT-FAMILY: Gulim, =EA=B5=B4=EB=A6=BC=
, sans-serif; COLOR: rgb(0,0,0)">Best regards,</SPAN><BR style=3D"FON=
T-SIZE: 14px; FONT-FAMILY: Gulim, =EA=B5=B4=EB=A6=BC, sans-serif; COLOR: rg=
b(0,0,0)"><SPAN style=3D"FONT-SIZE: 11pt"><SPAN style=3D"FONT-FAMILY: Gulim=
, =EA=B5=B4=EB=A6=BC, sans-serif; COLOR: rgb(0,0,0)">Dr. </SPAN></SPAN=
>Yasunobu Otsuga</DIV>
<DIV><SPAN style=3D"FONT-SIZE: 11pt; FONT-FAMILY: Gulim, =EA=B5=B4=EB=A6=BC=
, sans-serif; COLOR: rgb(0,0,0)">President & CEO</SPAN></DIV>
<DIV>Daito Pharmaceutical Co., Ltd.</DIV>
<DIV>326 Yokamachi, Toyama City, Toyama Prefecture 939-8567</DIV></DIV></BO=
DY></HTML>
--===============1864159637==--